The SNCA gene gives your body instructions for alpha-synuclein, a protein that supports communication between nerve cells, especially in the brain. This gene plays an important role in how nerve cells handle chemical messages. When the gene is changed or overactive, alpha-synuclein can form clumps that damage brain cells. Certain SNCA variants are linked to inherited Parkinson disease and may contribute to related conditions such as dementia with Lewy bodies.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes contain the information needed to produce proteins, the molecules that do the work in cells. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SNCAGene function
What if the gene works
The SNCA gene helps nerve cells in the brain handle chemical messaging. Its protein is found near synapses, the connection points between nerve cells, where it supports the storage and release of chemical messengers.
Risk
What if the gene does not work
Changes in the SNCA gene can cause inherited Parkinson disease, often starting earlier in adulthood and sometimes including dementia or autonomic symptoms. Effects can range from milder to more severe, with some variants linked to earlier onset and broader symptoms.
Treatment
What does that mean for your treatment
No SNCA-specific treatment or drug-choice guideline is currently established for people with pathogenic variants in the SNCA gene. The SNCA gene is a major research target, with treatments that aim to lower or clear alpha-synuclein, the protein made from this gene, under study.
Conditions associated with SNCA
Gene function
What if the gene works
Much of what the SNCA gene does in nerve cells relates to everyday communication between brain cells. It gives instructions for alpha-synuclein, a protein found in high amounts at the ends of nerve cells where messages are passed on. This protein helps keep signaling organized and supports smooth handling of tiny membrane packets inside cells.
Inside nerve cells, alpha-synuclein helps manage the tiny packets that store chemical messengers. It supports the timing and flow of signal release at synapses, the contact points where one nerve cell talks to another.
The protein helps move and reuse the small membrane packets needed for repeated signaling. This lets nerve cells keep sending messages during steady, everyday activity.
Alpha-synuclein attaches to fatty cell membranes and helps them keep the curved shapes needed for packet budding and movement. By doing this, it supports normal traffic near the nerve ending.
What is a variant?
Within a gene, a genetic variant is a small difference in its DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SNCA gene can change how alpha-synuclein folds, how much of it cells make, or how easily it is cleared away. In people reading about how SNCA gene variants affect Parkinson disease, these changes can make the protein stick together and build up inside nerve cells. Milder variants may cause smaller shifts in protein behavior. More severe variants, including extra copies of the gene, often cause greater buildup and may be linked to earlier symptoms.
How variants are linked to conditions
Among SNCA gene variants linked to Parkinson disease, rare pathogenic changes and extra copies of the gene can cause inherited forms of the condition and may also be associated with dementia with Lewy bodies. Other, more common variants in the SNCA gene are linked to a higher chance of developing Parkinson disease in population studies, but they do not mean a person will definitely develop it.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors play a role. In other cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For disease-causing SNCA changes, the gene variant itself is the main driver of risk. In some families, having extra copies of SNCA can raise the chance of Parkinson’s disease and may lead to symptoms starting earlier, while age can also affect when signs appear.
Inheritance of SNCA variants
The inheritance of SNCA gene variants linked to familial Parkinson disease is usually autosomal dominant. This means a parent carrying a disease-causing variant in the SNCA gene can pass it to a child with a 50% chance in each pregnancy. Men and women are affected and can pass it on equally, including from father to son. Not everyone who inherits an SNCA variant will develop symptoms in the same way or at the same age.
What does my SNCA result mean for my family?
For disease-causing changes in the SNCA gene, the family pattern is usually dominant, which means close relatives such as parents, brothers, sisters, and children may also carry the same change and could consider family testing. Not everyone with a SNCA change will be affected in exactly the same way or at the same age. The meaning for relatives depends on whether the result is a clearly disease-causing change or a result that only affects risk.
Genetic information
Genetic testing
How you find out about variants
SNCA genetic testing for Parkinson's disease looks for variants or extra copies of the SNCA gene using a blood or saliva sample. A lab reads the gene's DNA code and may also check whether pieces are repeated. Results can show whether a known SNCA variant was found, but they do not predict exactly if or when symptoms will appear.
When should I consider getting a genetic test?
Genetic testing for the SNCA gene may be considered if Parkinson's disease runs strongly in your family, especially when symptoms start unusually early or several relatives are affected across generations. It can also help explain a rare inherited form of Parkinson's or Lewy body dementia in a family.
A genetic result is only one part of your health story
A genetic test result can be informative, but how much it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This is one reason the same treatment may help one person a lot, help another person less, or cause different side effects. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, which can influence how well a medicine works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It studies relationships between genes and drugs to help explain why treatments may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the SNCA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general concerns about symptoms, treatment changes, or side effects are best discussed with your doctor. Research on the SNCA gene has explored whether some gene changes may affect response to certain Parkinson's treatments, but this has not become routine medical care.
History
The SNCA gene became a turning point in Parkinson’s disease research in the late 1990s, when families with inherited Parkinson’s were found to carry variants in this gene. Soon after, researchers identified the SNCA protein in Lewy bodies, the brain changes long linked to Parkinson’s on autopsy. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery helped connect family history, brain pathology, and genetics in one story. From these first observations, research expanded steadily. Extra copies of the SNCA gene were later shown to be linked to Parkinson’s as well, strengthening its place in the history of the condition. Today, the SNCA gene is widely seen as one of the landmark genes in modern Parkinson’s genetics.